MariMed Reports $44.2 Million Revenue and $4.7 Million Adjusted EBITDA
MariMed reported third-quarter 2026 revenue of $44.2 million, up from $40.8 million a year earlier, and net loss of $3.5 million. Gross margin was 38.8%, while adjusted EBITDA was $4.7 million. The company said quarterly revenue reached a record and it generated positive operating cash flow.Financi…